Incyte Corporation - Common Stock (NQ:INCY)
102.06
+0.30
(+0.29%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,723,045 |
| Open | 102.00 |
| Bid (Size) | 101.82 (100) |
| Ask (Size) | 102.50 (100) |
| Prev. Close | 101.76 |
| Today's Range | 101.40 - 103.20 |
| 52wk Range | 53.56 - 109.28 |
| Shares Outstanding | 222,430,635 |
| Dividend Yield | N/A |
Top News
More News
Spotting Winners: Natera (NASDAQ:NTRA) And Immuno-Oncology Stocks In Q3
November 19, 2025
Via StockStory
Topics
Artificial Intelligence
Performance
| YTD |
+46.8%
|
+46.8%
|
| 1 Month |
+15.9%
|
+15.9%
|
| 3 Month |
+20.0%
|
+20.0%
|
| 6 Month |
+58.9%
|
+58.9%
|
| 1 Year |
+45.0%
|
+45.0%
|
More News
Read More
Top S&P500 movers in Tuesday's pre-market session ↗
November 18, 2025
Via Chartmill
Via Chartmill
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗
November 18, 2025
Via The Motley Fool
Topics
Regulatory Compliance
Via The Motley Fool
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗
November 14, 2025
Via Benzinga
Topics
Artificial Intelligence
1 Mid-Cap Stock to Consider Right Now and 2 We Turn Down
November 13, 2025
Via StockStory
Peering Into Incyte Corp's Recent Short Interest ↗
November 12, 2025
Via Benzinga
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack
November 10, 2025
Via StockStory
Topics
Artificial Intelligence
Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks
November 10, 2025
Via StockStory
Topics
Artificial Intelligence
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
November 06, 2025
Via StockStory
Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings?
November 05, 2025
Via StockStory
The 5 Most Interesting Analyst Questions From Incyte’s Q3 Earnings Call
November 04, 2025
Via StockStory
Topics
Earnings
Stay informed with the top movers within the S&P500 index on Monday. ↗
November 03, 2025
Via Chartmill
Kenvue, IDEXX Laboratories, Freshpet And Other Big Stocks Moving Higher On Monday ↗
November 03, 2025
Via Benzinga
These S&P500 stocks have an unusual volume in today's session ↗
November 03, 2025
Via Chartmill
Via Chartmill
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
November 03, 2025
From Incyte
Via Business Wire
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms ↗
October 28, 2025
Via Benzinga
Topics
Intellectual Property
Frequently Asked Questions
Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 102.06
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 11/21/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 22.70B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 23B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>